We’re booking some profits on this health insurance stock after waiting out its slump
[ad_1] It’s taken some patience. But shares of this company finally broke through $500 each in Friday trading, so we’re ringing the register. [ad_2] Source link
Health insurance
Read More
World Heart Day 2023: Shifting Perspective From Protection To Prevention – Expert Speaks
[ad_1] World Heart Day is observed on September 29 every year with the aim of raising awareness about heart health and cardiovascular diseases and it serves as a reminder to everyone around the world to take care of their hearts. While timely intervention is needed to treat heart problems, experts say it’s important to focus…
Working women spend $15.4 billion more than men in out-of-pocket health costs, study finds
[ad_1] Luis Alvarez | Digitalvision | Getty Images High health-care costs are hitting women in the U.S. workforce much harder than men. Working women spend $15.4 billion more in out-of-pocket health expenses annually compared to their male counterparts, according to a new analysis of employer-sponsored health plans from Deloitte Consulting. The study found women spend…
Health care has had a tough year. Where we stand on our 5 stocks in the sector
[ad_1] There’s Eli Lilly (LLY), and then there’s everybody else. That’s a simple way to describe the performance of the Club’s health-care holdings so far this year, in what’s been a challenging period for the industry overall. Of the 11 market sectors year to date, health care is the fourth worth-worst performer, falling 4%, followed…
Medicare pricing deal set to play a key role in Biden’s 2024 campaign pitch
[ad_1] U.S. President Joe Biden speaks about lowering health-care costs, in the East Room of the White House in Washington, D.C., Aug. 29, 2023. Saul Loeb | AFP | Getty Images WASHINGTON — President Joe Biden is placing a priority on reducing individual health-care costs as he seeks reelection in a country where medical spending…
These are the top 5 performing Club stocks from mid-July to our August Monthly Meeting
[ad_1] Since the CNBC Investing Club’s July Monthly Meeting, the stock market has seesawed up and then down on a slew of quarterly earnings results and inflation data. That’s left Wall Street struggling this month. Here’s a look at the best performers from the Club’s 36 holdings from the market close after the July 12…
Blue Shield of California taps Amazon, Mark Cuban’s Cost Plus Drugs for its pharmacy network
[ad_1] Source: Blue Shield of California Blue Shield of California is teaming up with Mark Cuban’s Cost Plus Drug Company and Amazon Pharmacy — turning away from traditional drug store chains and ditching in part health giant CVS — in a move to save on drug costs for its 4.8 million members. The CEO of…
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
[ad_1] A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. Jim Vondruska | Reuters Novo Nordisk‘s obesity drug Wegovy slashed the risk of serious heart problems by 20% in a large clinical trial – a landmark finding that could put…
Amazon to offer reproductive care to more than 1 million employees through partnership with Maven Clinic
[ad_1] Amazon, the United States’ second-largest employer, will now offer fertility and family planning services to employees through a partnership with Maven Clinic. The free offering will be available to more than 1 million eligible Amazon employees spread across 50 countries outside of the U.S. and Canada. Through this partnership, Amazon employees and their partners…
Humana calms Wall Street’s jitters with quarterly results, clearing way for stock to run higher
[ad_1] Humana (HUM) reported second-quarter results Wednesday that were much better than feared, sending its stock price soaring and giving us the confidence to stick with the jilted health insurer. Revenue for the three months ended June 30 rose 13% year-over-year, to $26.75 billion, exceeding analysts’ estimates of $26.23 billion, according to Refinitiv. Adjusted earnings-per-share…